Andrej Dukát, Lucia Mistríková, Peter Sabaka, Peter Gavorník, Milan Kriška, Michal Pecík, Ľudovít Gašpar
Already ten years have passed from the world’s initiative for residual risk reduction. Despite many discoveries in the
field of therapeutic measures significant decrease of the residual risk could not be achieved. It is the complex of lipids,
diabetes mellitus, arterial hypertension, smoking, etc. The progress was achieved in the fields of dyslipidemias. This
overview brings the current review of possible measures in this topic.